Revenue
2018
2019
2020
2021
2022
2023
2024
2025
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $8,000 | $3.4M | $1.2M | $1.8M | $545,000 | $2.2M | $2.5M | $2.4M | $444,000 | — | — | — |
| Research & development | $43,000 | $9.2M | $44.0M | $52.0M | $47.1M | $47.5M | $41.9M | $38.0M | $30.3M | $15.0M | $18.9M | $10.5M | $4.4M |
| Operating expenses | $4.0M | $41.0M | $58.5M | $68.6M | $62.5M | $61.0M | $56.6M | $53.8M | $43.3M | $21.4M | $25.0M | $15.8M | $6.8M |
| Operating income | −$4.0M | −$41.0M | −$55.2M | −$67.4M | −$60.8M | −$60.5M | −$54.4M | −$51.2M | −$40.8M | −$21.0M | — | — | — |
| EBITDAderived | — | — | — | — | — | — | — | — | — | −$20.8M | — | — | — |
| Net income | −$1.0M | −$23.4M | −$61.3M | −$66.1M | −$60.6M | −$59.2M | −$51.4M | −$48.4M | −$40.4M | −$21.0M | −$25.0M | −$15.8M | −$6.4M |
| Basic EPSper diluted share | -$0.08 | -$1.92 | -$9.42 | -$13.83 | -$1.09 | -$1.65 | -$1.70 | -$2.03 | -$6.00 | -$1.26 | -$5.85 | -$291.00 | -$4,408.65 |
| Diluted EPSper diluted share | -$0.08 | -$1.92 | -$9.42 | -$13.83 | -$1.09 | -$1.65 | -$1.70 | -$2.03 | -$6.00 | -$1.26 | -$5.85 | -$291.00 | -$4,408.65 |
| Transaction | Insider | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Oct 29, 2025Form 4 | Dooley Mary BethSee Remarks below | SellCommon Stock | 157 | $1.81 | $284.17 | 12.7K |
| Apr 2, 2025Form 4 | Dooley Mary BethSee Remarks below | SellCommon Stock | 144 | $1.20 | $172.80 | 12.9K |
| Feb 3, 2025Form 4 | Dooley Mary BethSee Remarks below | SellCommon Stock | 2.1K | $1.33 | $2.8K | 13.0K |
| Oct 29, 2024Form 4 | Dooley Mary BethHead of Finance | SellCommon Stock | 79 | $1.40 | $110.60 | 15.2K |